Current Understanding of Biomarkers in Post Traumatic Stress Disorder and Mild Traumatic Brain Injury: A Systematic Review and Implications for Research and Treatment

For nearly 100 years, it was erroneously believed that the loss of consciousness and/or the altered mental status associated with a mild traumatic brain injury (mTBI) offered protection from the development of posttraumatic stress disorder (PTSD). However, it is now accepted that it is possible for PTSD to result from mTBI, and that the co-occurrence of these two conditions creates a more difficult condition to treat and worsens prognosis. In addition, it is known that the symptomology associated with PTSD and mTBI have a great deal of overlap, complicating diagnoses. The objective of this chapter is to review the current state of biomarkers aimed at diagnosing comorbid mTBI and PTSD that are useful on a single-patient basis and are not reliant on self-report or arduous interviews. Further, implications for future research and treatment are discussed